Get the Stockscreener App
7.23
2.82%
-0.21
After Hours:
7.23
Terns Pharmaceuticals Inc stock is traded at $7.23, with a volume of 2.27M.
It is down -2.82% in the last 24 hours and up +10.72% over the past month.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$7.44
Open:
$7.43
24h Volume:
2.27M
Relative Volume:
2.14
Market Cap:
$632.70M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-5.4773
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
+0.14%
1M Performance:
+10.72%
6M Performance:
+97.54%
1Y Performance:
-23.97%
1-Day Range:
$7.147
$7.48
1-Week Range:
$6.99
$7.67
52-Week Range:
$1.865
$10.70
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
Name
Terns Pharmaceuticals Inc
Sector
Industry
Phone
650-525-5535 EXT.101
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
7.23 | 653.71M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | H.C. Wainwright | Neutral |
| Feb-28-25 | Initiated | William Blair | Mkt Perform |
| Oct-31-24 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Mizuho | Buy |
| Jun-07-23 | Initiated | Jefferies | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-08-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-14-23 | Initiated | JMP Securities | Mkt Outperform |
| Feb-07-23 | Initiated | UBS | Buy |
| Sep-12-22 | Initiated | H.C. Wainwright | Neutral |
| Sep-14-21 | Resumed | Goldman | Buy |
| Mar-02-21 | Initiated | Cowen | Outperform |
| Mar-02-21 | Initiated | Goldman | Buy |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
View All
Terns Pharmaceuticals Inc Stock (TERN) Latest News
Terns Pharmaceuticals Inc. stock outlook for YEARWeekly Investment Report & Community Trade Idea Sharing - Newser
What candlestick patterns are forming on Terns Pharmaceuticals Inc.Earnings Recap Summary & Consistent Income Trade Recommendations - Newser
Using RSI to spot recovery in Terns Pharmaceuticals Inc.July 2025 Momentum & Reliable Intraday Trade Plans - Newser
Can technical indicators confirm Terns Pharmaceuticals Inc.’s reversalWatch List & Real-Time Buy Signal Alerts - Newser
Exit strategy if you’re trapped in Terns Pharmaceuticals Inc.Trade Entry Summary & Safe Capital Allocation Plans - Newser
Will Terns Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Recap & High Accuracy Buy Signal Tips - Newser
Is Terns Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Big Picture & Safe Entry Point Identification - Newser
Chart based exit strategy for Terns Pharmaceuticals Inc.Trade Performance Summary & Long-Term Capital Growth Strategies - Newser
Historical volatility pattern of Terns Pharmaceuticals Inc. visualizedStop Loss & Long-Term Growth Stock Strategies - Newser
Custom watchlist performance reports with Terns Pharmaceuticals Inc.Treasury Yields & Real-Time Stock Entry Alerts - Newser
Using data filters to optimize entry into Terns Pharmaceuticals Inc.Portfolio Update Summary & Free Risk Controlled Daily Trade Plans - Newser
Is Terns Pharmaceuticals Inc. building a consolidation baseBuy Signal & Safe Capital Investment Plans - Newser
Will breakout in Terns Pharmaceuticals Inc. lead to full recoveryEarnings Recap Report & Technical Analysis for Trade Confirmation - Newser
Using flow based indicators on Terns Pharmaceuticals Inc.July 2025 Reactions & Low Risk Entry Point Guides - Newser
Key metrics from Terns Pharmaceuticals Inc.’s quarterly dataTrade Exit Summary & Weekly Stock Breakout Alerts - Newser
Terns Pharmaceuticals Inc. stock chart pattern explainedTrade Ideas & AI Enhanced Trading Signals - Newser
Sentiment analysis tools applied to Terns Pharmaceuticals Inc.Portfolio Growth Summary & High Conviction Buy Zone Picks - Newser
Is this a good reentry point in Terns Pharmaceuticals Inc.2025 Stock Rankings & Weekly Watchlist of Top Performers - Newser
When is the best time to exit Terns Pharmaceuticals Inc.2025 Market Trends & Scalable Portfolio Growth Methods - Newser
Published on: 2025-09-12 03:49:06 - Newser
Published on: 2025-09-11 17:30:30 - Newser
Using Python tools to backtest Terns Pharmaceuticals Inc. strategiesWall Street Watch & Accurate Entry/Exit Alerts - Newser
Doing good in people’s lives: Amy Burroughs discusses CML - pharmaphorum
Visual analytics tools that track Terns Pharmaceuticals Inc. performanceJuly 2025 News Drivers & Verified Swing Trading Watchlist - Newser
Terns Pharmaceuticals Inc. recovery potential after sell off2025 Performance Recap & Advanced Technical Analysis Signals - Newser
Chart overlay techniques for tracking Terns Pharmaceuticals Inc.Market Weekly Review & Long-Term Safe Investment Plans - Newser
will breakout in terns pharmaceuticals inc. lead to full recoveryJuly 2025 Reactions & High Conviction Investment Ideas - Newser
What moving averages say about Terns Pharmaceuticals Inc.2025 Price Momentum & Growth Oriented Trade Recommendations - Newser
Earnings visualization tools for Terns Pharmaceuticals Inc.Trade Risk Summary & Daily Stock Trend Watchlist - Newser
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - Newser
Trexquant Investment LP Cuts Stake in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
How to integrate Terns Pharmaceuticals Inc. into portfolio analysis tools2025 Market Outlook & Community Supported Trade Ideas - Newser
Invesco Ltd. Raises Holdings in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Terns Pharmaceuticals Inc Stock (TERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):